SCHILKE TOBIN (Chief Financial Officer) received a stock award from CRINETICS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/25/2026ACC: 0001628280-26-011728
Officer· Chief Financial Officer
Since Mar 2026
+82K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
82K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+32K
Price / share
—
Trade value
—
% of position
60.6%
2/23/2026
52.83K→84.83K
Total
Net shares
+32K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/23/2026 | A · Award | +32K | — | — | 60.6% | 52.83K | 84.83K |
| Total | +32K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
50K shares
Shares
+50K
Strike price
43.79
Held after
50K
Exercisable
—
2/23/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock50K shares | 2/23/2026 | A · Award | +50K | 43.79 | — | 50K |